Aldeyra Therapeutics, Inc.
Get $10 bonus on your first $100 deposit for ALDX
Get $10 bonus on your first $100 deposit for ALDX
Aldeyra Therapeutics, Inc. (ALDX) Stock Competitors & Peer Comparison
See (ALDX) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALDX | $1.59 | +2.92% | 91.8M | -2.72 | -$0.56 | N/A |
| VRTX | $440.62 | +1.46% | 109.7B | 28.21 | $15.31 | N/A |
| REGN | $774.89 | +1.55% | 79B | 18.35 | $41.44 | +0.47% |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| ARGX | $784.66 | +4.87% | 47.4B | 39.13 | $19.56 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $326.96 | -1.02% | 42.4B | 137.13 | $2.33 | N/A |
| INSM | $161.11 | -1.65% | 35.1B | -25.39 | -$6.42 | N/A |
| UTHR | $583.09 | +4.19% | 24.8B | 20.32 | $27.84 | N/A |
| BNTX | $91.57 | +0.32% | 22.5B | -16.47 | -$5.44 | N/A |
Stock Comparison
ALDX vs VRTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, VRTX has a market cap of 109.7B. Regarding current trading prices, ALDX is priced at $1.59, while VRTX trades at $440.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas VRTX's P/E ratio is 28.21. In terms of profitability, ALDX's ROE is -0.64%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, ALDX is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check VRTX's competition here
ALDX vs REGN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, REGN has a market cap of 79B. Regarding current trading prices, ALDX is priced at $1.59, while REGN trades at $774.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas REGN's P/E ratio is 18.35. In terms of profitability, ALDX's ROE is -0.64%, compared to REGN's ROE of +0.15%. Regarding short-term risk, ALDX is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check REGN's competition here
ALDX vs VRNA Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, ALDX is priced at $1.59, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas VRNA's P/E ratio is -102.80. In terms of profitability, ALDX's ROE is -0.64%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, ALDX is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check VRNA's competition here
ALDX vs ARGX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ARGX has a market cap of 47.4B. Regarding current trading prices, ALDX is priced at $1.59, while ARGX trades at $784.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ARGX's P/E ratio is 39.13. In terms of profitability, ALDX's ROE is -0.64%, compared to ARGX's ROE of +0.34%. Regarding short-term risk, ALDX is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ARGX's competition here
ALDX vs SGEN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, ALDX is priced at $1.59, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas SGEN's P/E ratio is -57.19. In terms of profitability, ALDX's ROE is -0.64%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, ALDX is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check SGEN's competition here
ALDX vs ALNY Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ALNY has a market cap of 42.4B. Regarding current trading prices, ALDX is priced at $1.59, while ALNY trades at $326.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ALNY's P/E ratio is 137.13. In terms of profitability, ALDX's ROE is -0.64%, compared to ALNY's ROE of +0.90%. Regarding short-term risk, ALDX is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ALNY's competition here
ALDX vs INSM Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, INSM has a market cap of 35.1B. Regarding current trading prices, ALDX is priced at $1.59, while INSM trades at $161.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas INSM's P/E ratio is -25.39. In terms of profitability, ALDX's ROE is -0.64%, compared to INSM's ROE of -1.68%. Regarding short-term risk, ALDX is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check INSM's competition here
ALDX vs UTHR Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, UTHR has a market cap of 24.8B. Regarding current trading prices, ALDX is priced at $1.59, while UTHR trades at $583.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas UTHR's P/E ratio is 20.32. In terms of profitability, ALDX's ROE is -0.64%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, ALDX is less volatile compared to UTHR. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check UTHR's competition here
ALDX vs BNTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, BNTX has a market cap of 22.5B. Regarding current trading prices, ALDX is priced at $1.59, while BNTX trades at $91.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas BNTX's P/E ratio is -16.47. In terms of profitability, ALDX's ROE is -0.64%, compared to BNTX's ROE of -0.06%. Regarding short-term risk, ALDX is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check BNTX's competition here
ALDX vs BGNE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, ALDX is priced at $1.59, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas BGNE's P/E ratio is -22.55. In terms of profitability, ALDX's ROE is -0.64%, compared to BGNE's ROE of +0.07%. Regarding short-term risk, ALDX is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check BGNE's competition here
ALDX vs RPRX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RPRX has a market cap of 20.1B. Regarding current trading prices, ALDX is priced at $1.59, while RPRX trades at $47.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RPRX's P/E ratio is 26.33. In terms of profitability, ALDX's ROE is -0.64%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, ALDX is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check RPRX's competition here
ALDX vs ROIV Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ROIV has a market cap of 19.9B. Regarding current trading prices, ALDX is priced at $1.59, while ROIV trades at $28.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ROIV's P/E ratio is -23.72. In terms of profitability, ALDX's ROE is -0.64%, compared to ROIV's ROE of -0.18%. Regarding short-term risk, ALDX is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ROIV's competition here
ALDX vs MRNA Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, MRNA has a market cap of 19.8B. Regarding current trading prices, ALDX is priced at $1.59, while MRNA trades at $51.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas MRNA's P/E ratio is -6.90. In terms of profitability, ALDX's ROE is -0.64%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, ALDX is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check MRNA's competition here
ALDX vs RVMD Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RVMD has a market cap of 19.1B. Regarding current trading prices, ALDX is priced at $1.59, while RVMD trades at $96.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RVMD's P/E ratio is -16.18. In terms of profitability, ALDX's ROE is -0.64%, compared to RVMD's ROE of -0.63%. Regarding short-term risk, ALDX is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check RVMD's competition here
ALDX vs DNA-WT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, ALDX is priced at $1.59, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, ALDX's ROE is -0.64%, compared to DNA-WT's ROE of -0.54%. Regarding short-term risk, ALDX is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check DNA-WT's competition here
ALDX vs INCY Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, INCY has a market cap of 18.6B. Regarding current trading prices, ALDX is priced at $1.59, while INCY trades at $94.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas INCY's P/E ratio is 14.62. In terms of profitability, ALDX's ROE is -0.64%, compared to INCY's ROE of +0.29%. Regarding short-term risk, ALDX is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check INCY's competition here
ALDX vs GMAB Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, GMAB has a market cap of 17.1B. Regarding current trading prices, ALDX is priced at $1.59, while GMAB trades at $28.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas GMAB's P/E ratio is 17.95. In terms of profitability, ALDX's ROE is -0.64%, compared to GMAB's ROE of +0.14%. Regarding short-term risk, ALDX is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check GMAB's competition here
ALDX vs SMMT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, SMMT has a market cap of 14.3B. Regarding current trading prices, ALDX is priced at $1.59, while SMMT trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas SMMT's P/E ratio is -13.35. In terms of profitability, ALDX's ROE is -0.64%, compared to SMMT's ROE of -2.97%. Regarding short-term risk, ALDX is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check SMMT's competition here
ALDX vs BBIO Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, BBIO has a market cap of 13.9B. Regarding current trading prices, ALDX is priced at $1.59, while BBIO trades at $74.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas BBIO's P/E ratio is -19.03. In terms of profitability, ALDX's ROE is -0.64%, compared to BBIO's ROE of +0.39%. Regarding short-term risk, ALDX is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check BBIO's competition here
ALDX vs ASND Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ASND has a market cap of 13.5B. Regarding current trading prices, ALDX is priced at $1.59, while ASND trades at $228.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ASND's P/E ratio is -50.57. In terms of profitability, ALDX's ROE is -0.64%, compared to ASND's ROE of +1.28%. Regarding short-term risk, ALDX is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check ASND's competition here
ALDX vs KRTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, ALDX is priced at $1.59, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas KRTX's P/E ratio is -28.09. In terms of profitability, ALDX's ROE is -0.64%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, ALDX is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check KRTX's competition here
ALDX vs IONS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, IONS has a market cap of 12.2B. Regarding current trading prices, ALDX is priced at $1.59, while IONS trades at $75.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas IONS's P/E ratio is -31.05. In terms of profitability, ALDX's ROE is -0.64%, compared to IONS's ROE of -0.69%. Regarding short-term risk, ALDX is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check IONS's competition here
ALDX vs EXEL Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, EXEL has a market cap of 11.8B. Regarding current trading prices, ALDX is priced at $1.59, while EXEL trades at $44.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas EXEL's P/E ratio is 15.82. In terms of profitability, ALDX's ROE is -0.64%, compared to EXEL's ROE of +0.37%. Regarding short-term risk, ALDX is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check EXEL's competition here
ALDX vs JAZZ Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, JAZZ has a market cap of 11.8B. Regarding current trading prices, ALDX is priced at $1.59, while JAZZ trades at $194.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas JAZZ's P/E ratio is -32.75. In terms of profitability, ALDX's ROE is -0.64%, compared to JAZZ's ROE of -0.09%. Regarding short-term risk, ALDX is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check JAZZ's competition here
ALDX vs MDGL Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, MDGL has a market cap of 11.7B. Regarding current trading prices, ALDX is priced at $1.59, while MDGL trades at $514.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas MDGL's P/E ratio is -39.84. In terms of profitability, ALDX's ROE is -0.64%, compared to MDGL's ROE of -0.44%. Regarding short-term risk, ALDX is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check MDGL's competition here
ALDX vs RNAM Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, ALDX is priced at $1.59, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RNAM's P/E ratio is -17.39. In terms of profitability, ALDX's ROE is -0.64%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, ALDX is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check RNAM's competition here
ALDX vs BMRN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, BMRN has a market cap of 10.8B. Regarding current trading prices, ALDX is priced at $1.59, while BMRN trades at $57.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas BMRN's P/E ratio is 31.23. In terms of profitability, ALDX's ROE is -0.64%, compared to BMRN's ROE of +0.06%. Regarding short-term risk, ALDX is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check BMRN's competition here
ALDX vs RXDX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, ALDX is priced at $1.59, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RXDX's P/E ratio is -56.47. In terms of profitability, ALDX's ROE is -0.64%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, ALDX is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check RXDX's competition here
ALDX vs PCVX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, PCVX has a market cap of 8.7B. Regarding current trading prices, ALDX is priced at $1.59, while PCVX trades at $61.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas PCVX's P/E ratio is -10.78. In terms of profitability, ALDX's ROE is -0.64%, compared to PCVX's ROE of -0.26%. Regarding short-term risk, ALDX is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check PCVX's competition here
ALDX vs IMGN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, ALDX is priced at $1.59, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas IMGN's P/E ratio is -111.55. In terms of profitability, ALDX's ROE is -0.64%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, ALDX is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check IMGN's competition here
ALDX vs AXSM Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, AXSM has a market cap of 8.6B. Regarding current trading prices, ALDX is priced at $1.59, while AXSM trades at $173.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas AXSM's P/E ratio is -45.98. In terms of profitability, ALDX's ROE is -0.64%, compared to AXSM's ROE of -2.54%. Regarding short-term risk, ALDX is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check AXSM's competition here
ALDX vs ARWR Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ARWR has a market cap of 8.6B. Regarding current trading prices, ALDX is priced at $1.59, while ARWR trades at $64.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ARWR's P/E ratio is 38.24. In terms of profitability, ALDX's ROE is -0.64%, compared to ARWR's ROE of +0.36%. Regarding short-term risk, ALDX is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ARWR's competition here
ALDX vs TECH Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, TECH has a market cap of 8.4B. Regarding current trading prices, ALDX is priced at $1.59, while TECH trades at $54.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas TECH's P/E ratio is 101.57. In terms of profitability, ALDX's ROE is -0.64%, compared to TECH's ROE of +0.04%. Regarding short-term risk, ALDX is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check TECH's competition here
ALDX vs BPMC Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, ALDX is priced at $1.59, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas BPMC's P/E ratio is -51.58. In terms of profitability, ALDX's ROE is -0.64%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, ALDX is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check BPMC's competition here
ALDX vs CERE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, ALDX is priced at $1.59, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CERE's P/E ratio is -16.47. In terms of profitability, ALDX's ROE is -0.64%, compared to CERE's ROE of -0.72%. Regarding short-term risk, ALDX is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CERE's competition here
ALDX vs CYTK Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CYTK has a market cap of 8.1B. Regarding current trading prices, ALDX is priced at $1.59, while CYTK trades at $66.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CYTK's P/E ratio is -10.01. In terms of profitability, ALDX's ROE is -0.64%, compared to CYTK's ROE of +1.73%. Regarding short-term risk, ALDX is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CYTK's competition here
ALDX vs KRYS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, KRYS has a market cap of 7.7B. Regarding current trading prices, ALDX is priced at $1.59, while KRYS trades at $264.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas KRYS's P/E ratio is 38.65. In terms of profitability, ALDX's ROE is -0.64%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, ALDX is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check KRYS's competition here
ALDX vs ABVX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ABVX has a market cap of 7.6B. Regarding current trading prices, ALDX is priced at $1.59, while ABVX trades at $118.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ABVX's P/E ratio is -20.84. In terms of profitability, ALDX's ROE is -0.64%, compared to ABVX's ROE of -1.59%. Regarding short-term risk, ALDX is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ABVX's competition here
ALDX vs HALO Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, HALO has a market cap of 7.5B. Regarding current trading prices, ALDX is priced at $1.59, while HALO trades at $65.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas HALO's P/E ratio is 24.84. In terms of profitability, ALDX's ROE is -0.64%, compared to HALO's ROE of +0.93%. Regarding short-term risk, ALDX is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check HALO's competition here
ALDX vs NUVL Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, NUVL has a market cap of 7.5B. Regarding current trading prices, ALDX is priced at $1.59, while NUVL trades at $103.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas NUVL's P/E ratio is -17.48. In terms of profitability, ALDX's ROE is -0.64%, compared to NUVL's ROE of -0.42%. Regarding short-term risk, ALDX is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check NUVL's competition here
ALDX vs MTSR Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, ALDX is priced at $1.59, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas MTSR's P/E ratio is -23.58. In terms of profitability, ALDX's ROE is -0.64%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, ALDX is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check MTSR's competition here
ALDX vs IBRX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, IBRX has a market cap of 7.1B. Regarding current trading prices, ALDX is priced at $1.59, while IBRX trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas IBRX's P/E ratio is -18.05. In terms of profitability, ALDX's ROE is -0.64%, compared to IBRX's ROE of +0.64%. Regarding short-term risk, ALDX is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check IBRX's competition here
ALDX vs KYMR Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, KYMR has a market cap of 6.9B. Regarding current trading prices, ALDX is priced at $1.59, while KYMR trades at $85.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas KYMR's P/E ratio is -23.06. In terms of profitability, ALDX's ROE is -0.64%, compared to KYMR's ROE of -0.29%. Regarding short-term risk, ALDX is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check KYMR's competition here
ALDX vs MRUS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, ALDX is priced at $1.59, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas MRUS's P/E ratio is -17.05. In terms of profitability, ALDX's ROE is -0.64%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, ALDX is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check MRUS's competition here
ALDX vs ACLX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, ALDX is priced at $1.59, while ACLX trades at $114.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ACLX's P/E ratio is -28.21. In terms of profitability, ALDX's ROE is -0.64%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, ALDX is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ACLX's competition here
ALDX vs BLTE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, BLTE has a market cap of 6.7B. Regarding current trading prices, ALDX is priced at $1.59, while BLTE trades at $178.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas BLTE's P/E ratio is -73.82. In terms of profitability, ALDX's ROE is -0.64%, compared to BLTE's ROE of -0.23%. Regarding short-term risk, ALDX is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check BLTE's competition here
ALDX vs PTGX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, PTGX has a market cap of 6.6B. Regarding current trading prices, ALDX is priced at $1.59, while PTGX trades at $102.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas PTGX's P/E ratio is -50.61. In terms of profitability, ALDX's ROE is -0.64%, compared to PTGX's ROE of -0.20%. Regarding short-term risk, ALDX is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check PTGX's competition here
ALDX vs RETA Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, ALDX is priced at $1.59, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RETA's P/E ratio is -66.29. In terms of profitability, ALDX's ROE is -0.64%, compared to RETA's ROE of +0.47%. Regarding short-term risk, ALDX is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check RETA's competition here
ALDX vs PRAX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, PRAX has a market cap of 6.5B. Regarding current trading prices, ALDX is priced at $1.59, while PRAX trades at $315.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas PRAX's P/E ratio is -22.77. In terms of profitability, ALDX's ROE is -0.64%, compared to PRAX's ROE of -0.59%. Regarding short-term risk, ALDX is less volatile compared to PRAX. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check PRAX's competition here
ALDX vs RYTM Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RYTM has a market cap of 5.9B. Regarding current trading prices, ALDX is priced at $1.59, while RYTM trades at $86.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RYTM's P/E ratio is -27.86. In terms of profitability, ALDX's ROE is -0.64%, compared to RYTM's ROE of -1.79%. Regarding short-term risk, ALDX is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check RYTM's competition here
ALDX vs CGON Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CGON has a market cap of 5.9B. Regarding current trading prices, ALDX is priced at $1.59, while CGON trades at $68.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CGON's P/E ratio is -33.56. In terms of profitability, ALDX's ROE is -0.64%, compared to CGON's ROE of -0.23%. Regarding short-term risk, ALDX is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check CGON's competition here
ALDX vs COGT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, COGT has a market cap of 5.8B. Regarding current trading prices, ALDX is priced at $1.59, while COGT trades at $36.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas COGT's P/E ratio is -16.49. In terms of profitability, ALDX's ROE is -0.64%, compared to COGT's ROE of -1.00%. Regarding short-term risk, ALDX is more volatile compared to COGT. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check COGT's competition here
ALDX vs PTCT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, PTCT has a market cap of 5.8B. Regarding current trading prices, ALDX is priced at $1.59, while PTCT trades at $71.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas PTCT's P/E ratio is 8.11. In terms of profitability, ALDX's ROE is -0.64%, compared to PTCT's ROE of -3.62%. Regarding short-term risk, ALDX is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check PTCT's competition here
ALDX vs SRRK Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, SRRK has a market cap of 5.7B. Regarding current trading prices, ALDX is priced at $1.59, while SRRK trades at $50.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas SRRK's P/E ratio is -15.17. In terms of profitability, ALDX's ROE is -0.64%, compared to SRRK's ROE of -1.46%. Regarding short-term risk, ALDX is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check SRRK's competition here
ALDX vs CDTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, ALDX is priced at $1.59, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CDTX's P/E ratio is -19.77. In terms of profitability, ALDX's ROE is -0.64%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, ALDX is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CDTX's competition here
ALDX vs CELC Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CELC has a market cap of 5.6B. Regarding current trading prices, ALDX is priced at $1.59, while CELC trades at $115.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CELC's P/E ratio is -30.49. In terms of profitability, ALDX's ROE is -0.64%, compared to CELC's ROE of -2.03%. Regarding short-term risk, ALDX is more volatile compared to CELC. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CELC's competition here
ALDX vs ABCM Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, ALDX is priced at $1.59, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, ALDX's ROE is -0.64%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, ALDX is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ABCM's competition here
ALDX vs ISEE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, ALDX is priced at $1.59, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ISEE's P/E ratio is -22.44. In terms of profitability, ALDX's ROE is -0.64%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, ALDX is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ISEE's competition here
ALDX vs ALKS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ALKS has a market cap of 5.5B. Regarding current trading prices, ALDX is priced at $1.59, while ALKS trades at $34.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ALKS's P/E ratio is 23.09. In terms of profitability, ALDX's ROE is -0.64%, compared to ALKS's ROE of +0.14%. Regarding short-term risk, ALDX is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ALKS's competition here
ALDX vs TGTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, TGTX has a market cap of 5.3B. Regarding current trading prices, ALDX is priced at $1.59, while TGTX trades at $33.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas TGTX's P/E ratio is 12.05. In terms of profitability, ALDX's ROE is -0.64%, compared to TGTX's ROE of +1.01%. Regarding short-term risk, ALDX is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check TGTX's competition here
ALDX vs FBIOX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, FBIOX has a market cap of 5.3B. Regarding current trading prices, ALDX is priced at $1.59, while FBIOX trades at $25.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas FBIOX's P/E ratio is N/A. In terms of profitability, ALDX's ROE is -0.64%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, ALDX is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check FBIOX's competition here
ALDX vs CNTA Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CNTA has a market cap of 5.3B. Regarding current trading prices, ALDX is priced at $1.59, while CNTA trades at $39.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CNTA's P/E ratio is -27.09. In terms of profitability, ALDX's ROE is -0.64%, compared to CNTA's ROE of -0.51%. Regarding short-term risk, ALDX is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CNTA's competition here
ALDX vs ERAS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ERAS has a market cap of 5.3B. Regarding current trading prices, ALDX is priced at $1.59, while ERAS trades at $17.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ERAS's P/E ratio is -38.77. In terms of profitability, ALDX's ROE is -0.64%, compared to ERAS's ROE of -0.34%. Regarding short-term risk, ALDX is more volatile compared to ERAS. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ERAS's competition here
ALDX vs CAI Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CAI has a market cap of 5.3B. Regarding current trading prices, ALDX is priced at $1.59, while CAI trades at $19.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CAI's P/E ratio is -5.82. In terms of profitability, ALDX's ROE is -0.64%, compared to CAI's ROE of +0.25%. Regarding short-term risk, ALDX is more volatile compared to CAI. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CAI's competition here
ALDX vs APLS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, APLS has a market cap of 5.2B. Regarding current trading prices, ALDX is priced at $1.59, while APLS trades at $40.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas APLS's P/E ratio is 226.11. In terms of profitability, ALDX's ROE is -0.64%, compared to APLS's ROE of +0.08%. Regarding short-term risk, ALDX is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check APLS's competition here
ALDX vs IMVT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, IMVT has a market cap of 5B. Regarding current trading prices, ALDX is priced at $1.59, while IMVT trades at $24.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas IMVT's P/E ratio is -9.22. In terms of profitability, ALDX's ROE is -0.64%, compared to IMVT's ROE of -0.66%. Regarding short-term risk, ALDX is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check IMVT's competition here
ALDX vs MIRM Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, MIRM has a market cap of 4.8B. Regarding current trading prices, ALDX is priced at $1.59, while MIRM trades at $96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas MIRM's P/E ratio is -203.51. In terms of profitability, ALDX's ROE is -0.64%, compared to MIRM's ROE of -0.09%. Regarding short-term risk, ALDX is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check MIRM's competition here
ALDX vs CRSP Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CRSP has a market cap of 4.8B. Regarding current trading prices, ALDX is priced at $1.59, while CRSP trades at $51.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CRSP's P/E ratio is -7.68. In terms of profitability, ALDX's ROE is -0.64%, compared to CRSP's ROE of -0.32%. Regarding short-term risk, ALDX is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CRSP's competition here
ALDX vs TERN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, TERN has a market cap of 4.7B. Regarding current trading prices, ALDX is priced at $1.59, while TERN trades at $52.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas TERN's P/E ratio is -51.09. In terms of profitability, ALDX's ROE is -0.64%, compared to TERN's ROE of -0.20%. Regarding short-term risk, ALDX is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check TERN's competition here
ALDX vs APGE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, APGE has a market cap of 4.7B. Regarding current trading prices, ALDX is priced at $1.59, while APGE trades at $82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas APGE's P/E ratio is -19.73. In terms of profitability, ALDX's ROE is -0.64%, compared to APGE's ROE of -0.37%. Regarding short-term risk, ALDX is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check APGE's competition here
ALDX vs XENE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, XENE has a market cap of 4.6B. Regarding current trading prices, ALDX is priced at $1.59, while XENE trades at $56.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas XENE's P/E ratio is -13.22. In terms of profitability, ALDX's ROE is -0.64%, compared to XENE's ROE of -0.56%. Regarding short-term risk, ALDX is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check XENE's competition here
ALDX vs FOLD Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, ALDX is priced at $1.59, while FOLD trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas FOLD's P/E ratio is -160.78. In terms of profitability, ALDX's ROE is -0.64%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, ALDX is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check FOLD's competition here
ALDX vs AKRO Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, ALDX is priced at $1.59, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas AKRO's P/E ratio is -14.57. In terms of profitability, ALDX's ROE is -0.64%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, ALDX is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check AKRO's competition here
ALDX vs ALPN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, ALDX is priced at $1.59, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ALPN's P/E ratio is -101.52. In terms of profitability, ALDX's ROE is -0.64%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, ALDX is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ALPN's competition here
ALDX vs CORT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CORT has a market cap of 4.4B. Regarding current trading prices, ALDX is priced at $1.59, while CORT trades at $42.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CORT's P/E ratio is 50.84. In terms of profitability, ALDX's ROE is -0.64%, compared to CORT's ROE of +0.15%. Regarding short-term risk, ALDX is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CORT's competition here
ALDX vs OPT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, ALDX is priced at $1.59, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas OPT's P/E ratio is -1.52. In terms of profitability, ALDX's ROE is -0.64%, compared to OPT's ROE of +0.88%. Regarding short-term risk, ALDX is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check OPT's competition here
ALDX vs MRTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, ALDX is priced at $1.59, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas MRTX's P/E ratio is -4.82. In terms of profitability, ALDX's ROE is -0.64%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, ALDX is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check MRTX's competition here
ALDX vs LGND Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, LGND has a market cap of 4.1B. Regarding current trading prices, ALDX is priced at $1.59, while LGND trades at $207.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas LGND's P/E ratio is 33.40. In terms of profitability, ALDX's ROE is -0.64%, compared to LGND's ROE of +0.14%. Regarding short-term risk, ALDX is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check LGND's competition here
ALDX vs CRNX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CRNX has a market cap of 4B. Regarding current trading prices, ALDX is priced at $1.59, while CRNX trades at $39.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CRNX's P/E ratio is -7.76. In terms of profitability, ALDX's ROE is -0.64%, compared to CRNX's ROE of -0.41%. Regarding short-term risk, ALDX is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CRNX's competition here
ALDX vs NAMS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, NAMS has a market cap of 3.9B. Regarding current trading prices, ALDX is priced at $1.59, while NAMS trades at $33.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas NAMS's P/E ratio is -19.72. In terms of profitability, ALDX's ROE is -0.64%, compared to NAMS's ROE of -0.27%. Regarding short-term risk, ALDX is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check NAMS's competition here
ALDX vs VKTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, VKTX has a market cap of 3.9B. Regarding current trading prices, ALDX is priced at $1.59, while VKTX trades at $33.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas VKTX's P/E ratio is -10.57. In terms of profitability, ALDX's ROE is -0.64%, compared to VKTX's ROE of -0.48%. Regarding short-term risk, ALDX is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check VKTX's competition here
ALDX vs ACAD Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ACAD has a market cap of 3.8B. Regarding current trading prices, ALDX is priced at $1.59, while ACAD trades at $22.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ACAD's P/E ratio is 9.60. In terms of profitability, ALDX's ROE is -0.64%, compared to ACAD's ROE of +0.42%. Regarding short-term risk, ALDX is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check ACAD's competition here
ALDX vs RYZB Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, ALDX is priced at $1.59, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas RYZB's P/E ratio is -57.86. In terms of profitability, ALDX's ROE is -0.64%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, ALDX is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check RYZB's competition here
ALDX vs CBAY Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, ALDX is priced at $1.59, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CBAY's P/E ratio is -32.81. In terms of profitability, ALDX's ROE is -0.64%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, ALDX is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CBAY's competition here
ALDX vs KNSA Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, KNSA has a market cap of 3.6B. Regarding current trading prices, ALDX is priced at $1.59, while KNSA trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas KNSA's P/E ratio is 65.25. In terms of profitability, ALDX's ROE is -0.64%, compared to KNSA's ROE of +0.11%. Regarding short-term risk, ALDX is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check KNSA's competition here
ALDX vs SWTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, ALDX is priced at $1.59, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas SWTX's P/E ratio is -13.78. In terms of profitability, ALDX's ROE is -0.64%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, ALDX is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check SWTX's competition here
ALDX vs EWTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, EWTX has a market cap of 3.5B. Regarding current trading prices, ALDX is priced at $1.59, while EWTX trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas EWTX's P/E ratio is -19.94. In terms of profitability, ALDX's ROE is -0.64%, compared to EWTX's ROE of -0.32%. Regarding short-term risk, ALDX is less volatile compared to EWTX. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check EWTX's competition here
ALDX vs LEGN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, LEGN has a market cap of 3.3B. Regarding current trading prices, ALDX is priced at $1.59, while LEGN trades at $18.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas LEGN's P/E ratio is -11.10. In terms of profitability, ALDX's ROE is -0.64%, compared to LEGN's ROE of -0.29%. Regarding short-term risk, ALDX is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check LEGN's competition here
ALDX vs DNTH Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, DNTH has a market cap of 3.3B. Regarding current trading prices, ALDX is priced at $1.59, while DNTH trades at $86.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas DNTH's P/E ratio is -20.52. In terms of profitability, ALDX's ROE is -0.64%, compared to DNTH's ROE of +0.00%. Regarding short-term risk, ALDX is less volatile compared to DNTH. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check DNTH's competition here
ALDX vs LQDA Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, LQDA has a market cap of 3.3B. Regarding current trading prices, ALDX is priced at $1.59, while LQDA trades at $37.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas LQDA's P/E ratio is -46.70. In terms of profitability, ALDX's ROE is -0.64%, compared to LQDA's ROE of -2.09%. Regarding short-term risk, ALDX is more volatile compared to LQDA. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check LQDA's competition here
ALDX vs TLX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, TLX has a market cap of 3.3B. Regarding current trading prices, ALDX is priced at $1.59, while TLX trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas TLX's P/E ratio is -481.50. In terms of profitability, ALDX's ROE is -0.64%, compared to TLX's ROE of -0.02%. Regarding short-term risk, ALDX is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check TLX's competition here
ALDX vs GPCR Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, GPCR has a market cap of 3.1B. Regarding current trading prices, ALDX is priced at $1.59, while GPCR trades at $54.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas GPCR's P/E ratio is -22.78. In terms of profitability, ALDX's ROE is -0.64%, compared to GPCR's ROE of -0.15%. Regarding short-term risk, ALDX is less volatile compared to GPCR. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check GPCR's competition here
ALDX vs SYRE Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, SYRE has a market cap of 3.1B. Regarding current trading prices, ALDX is priced at $1.59, while SYRE trades at $50.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas SYRE's P/E ratio is -25.86. In terms of profitability, ALDX's ROE is -0.64%, compared to SYRE's ROE of -0.29%. Regarding short-term risk, ALDX is less volatile compared to SYRE. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check SYRE's competition here
ALDX vs DNLI Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, DNLI has a market cap of 3.1B. Regarding current trading prices, ALDX is priced at $1.59, while DNLI trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas DNLI's P/E ratio is -6.54. In terms of profitability, ALDX's ROE is -0.64%, compared to DNLI's ROE of -0.50%. Regarding short-term risk, ALDX is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check DNLI's competition here
ALDX vs CPRX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, CPRX has a market cap of 3.1B. Regarding current trading prices, ALDX is priced at $1.59, while CPRX trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas CPRX's P/E ratio is 14.88. In terms of profitability, ALDX's ROE is -0.64%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, ALDX is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for ALDX.Check CPRX's competition here
ALDX vs DYN Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, DYN has a market cap of 3B. Regarding current trading prices, ALDX is priced at $1.59, while DYN trades at $18.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas DYN's P/E ratio is -5.23. In terms of profitability, ALDX's ROE is -0.64%, compared to DYN's ROE of -0.61%. Regarding short-term risk, ALDX is less volatile compared to DYN. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check DYN's competition here
ALDX vs TARS Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, TARS has a market cap of 2.9B. Regarding current trading prices, ALDX is priced at $1.59, while TARS trades at $70.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas TARS's P/E ratio is -43.25. In terms of profitability, ALDX's ROE is -0.64%, compared to TARS's ROE of -0.20%. Regarding short-term risk, ALDX is less volatile compared to TARS. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check TARS's competition here
ALDX vs TVTX Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, TVTX has a market cap of 2.9B. Regarding current trading prices, ALDX is priced at $1.59, while TVTX trades at $31.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas TVTX's P/E ratio is -55.56. In terms of profitability, ALDX's ROE is -0.64%, compared to TVTX's ROE of -0.79%. Regarding short-term risk, ALDX is less volatile compared to TVTX. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check TVTX's competition here
ALDX vs ARQT Comparison April 2026
ALDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALDX stands at 91.8M. In comparison, ARQT has a market cap of 2.9B. Regarding current trading prices, ALDX is priced at $1.59, while ARQT trades at $24.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALDX currently has a P/E ratio of -2.72, whereas ARQT's P/E ratio is -179.00. In terms of profitability, ALDX's ROE is -0.64%, compared to ARQT's ROE of -0.10%. Regarding short-term risk, ALDX is less volatile compared to ARQT. This indicates potentially lower risk in terms of short-term price fluctuations for ALDX.Check ARQT's competition here